Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2024-2026. The procurement contains two options to …

CPV: 33650000 Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores, 33651000 Antiinfecciosos generales para uso sistémico, vacunas, 33651600 Vacunas
Lugar de ejecución:
Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028)
Organismo adjudicador:
Ministry of Social Affairs and Health
Número de premio:
THL/1106/2.02.06/2023

1. Buyer

1.1 Buyer

Official name : Ministry of Social Affairs and Health
Legal type of the buyer : Central government authority
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028)
Description : The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2024-2026. The procurement contains two options to extend the contract for the periods 2026-2027 and 2027-2028. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Procedure identifier : d930c52a-3b4f-4004-8c93-c57c008a4917
Previous notice : 8a38e69f-f493-4f54-9926-4425b1ae1515-01
Internal identifier : THL/1106/2.02.06/2023
Type of procedure : Open
The procedure is accelerated : no
Justification for the accelerated procedure :
Main features of the procedure : An open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive bidding, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651600 Vaccines
Additional classification ( cpv ): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Additional classification ( cpv ): 33651000 General anti-infectives for systemic use and vaccines

2.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland

2.1.4 General information

Additional information : The purpose of STM and the Customer is to procure Human Papillomavirus Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for children aged 10 or older. Syringes without fixed needles are preferred. This procurement is not divided into separate lots. The vaccines are intended for the National Vaccination Programme for use by wellbeing services county and eventually municipalities and thus the need to coordinate the various contracting partners of separate lots could jeopardise the proper implementation of national immunization programme. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/hpv-or-human-papillomavirus-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
Legal basis :
Directive 2014/24/EU

5. Lot

5.1 Lot technical ID : LOT-0000

Title : Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028)
Description : The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2024-2026. The procurement contains two options to extend the contract for the periods 2026-2027 and 2027-2028. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Internal identifier : 772316

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651600 Vaccines
Additional classification ( cpv ): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Additional classification ( cpv ): 33651000 General anti-infectives for systemic use and vaccines

5.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Additional information :

5.1.3 Estimated duration

Duration : 2 Year

5.1.4 Renewal

Maximum renewals : 2

5.1.6 General information

Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : yes
Additional information : The purpose of STM and the Customer is to procure Human Papillomavirus Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for children aged 10 or older. Syringes without fixed needles are preferred. This procurement is not divided into separate lots. The vaccines are intended for the National Vaccination Programme for use by wellbeing services county and eventually municipalities and thus the need to coordinate the various contracting partners of separate lots could jeopardise the proper implementation of national immunization programme. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/hpv-or-human-papillomavirus-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

5.1.10 Award criteria

Criterion :
Type : Price
Name :
Description : Price
Weight (points, exact) : 66
Criterion :
Type : Quality
Name :
Description : Quality
Weight (points, exact) : 34
Description of the method to be used if weighting cannot be expressed by criteria :
Justification for not indicating the weighting of the award criteria :

5.1.15 Techniques

Framework agreement :
No framework agreement
Information about the dynamic purchasing system :
No dynamic purchase system

5.1.16 Further information, mediation and review

Review organisation : Markkinaoikeus
TED eSender : Hansel Oy (Hilma)

6. Results

Value of all contracts awarded in this notice : 8 112 000 Euro

6.1 Result lot ldentifier : LOT-0000

At least one winner was chosen.

6.1.2 Information about winners

Winner :
Official name : GlaxoSmithKline Oy
Tender :
Tender identifier : tenderReference-3282910-772316
Identifier of lot or group of lots : LOT-0000
Subcontracting : No
Contract information :
Identifier of the contract : THL/1106/2.02.06/2023
Date on which the winner was chosen : 15/12/2023
Date of the conclusion of the contract : 05/11/2024
The contract is awarded within a framework agreement : no

6.1.4 Statistical information

Received tenders or requests to participate :
Type of received submissions : Tenders
Number of tenders or requests to participate received : 2

8. Organisations

8.1 ORG-0001

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0002

Official name : Ministry of Social Affairs and Health
Registration number : 0244685-8
Postal address : P.O. BOX 33
Town : Helsinki
Postcode : 00023
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Tuija Orre
Telephone : +358 295246000
Roles of this organisation :
Buyer

8.1 ORG-0003

Official name : GlaxoSmithKline Oy
Registration number : FI01083784
Postal address : Porkkalankatu 20 A
Town : Helsinki
Postcode : 00180
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : 0504200443
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000

8.1 ORG-0004

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

11. Notice information

11.1 Notice information

Notice identifier/version : 5b95f270-9563-408b-9a6f-37738502e640 - 01
Form type : Result
Notice type : Contract or concession award notice – standard regime
Notice dispatch date : 28/11/2024 12:55 +00:00
Notice dispatch date (eSender) : 28/11/2024 12:57 +00:00
Languages in which this notice is officially available : English

11.2 Publication information

Notice publication number : 00728827-2024
OJ S issue number : 233/2024
Publication date : 29/11/2024